Hospira

Hospira was a global healthcare company specializing in the development, manufacturing, and marketing of injectable drugs and infusion technologies, such as IV fluids and pumps. It focused on providing safe, reliable medications and delivery systems for hospitals and healthcare providers. In 2015, Hospira was acquired by Pfizer, a major pharmaceutical firm, expanding Pfizer’s portfolio in biosimilars (medical products almost identical to original biologic drugs). Hospira’s core mission was to improve patient care through innovative, cost-effective medical solutions, helping healthcare systems deliver effective treatments efficiently.